Most readers would already be aware that Cross Country Healthcare's (NASDAQ:CCRN) stock increased significantly by 30% over the past three months. We wonder if and what role the company's financials ...
Cross Country Healthcare's stock performance suggests investors expect a challenging period for the company. Long-term tailwinds include high capital turnover, compounding earnings, compressed ...
I previously rated CCRN a sell, arguing that the FTC could block the merger because of concerns about competition in healthcare markets. The stock price now offers a 45% upside if the Aya merger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results